Literature DB >> 19418581

High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells.

Carl Christoph Schimanski1, Kirsten Frerichs, Fareed Rahman, Martin Berger, Hauke Lang, Peter R Galle, Markus Moehler, Ines Gockel.   

Abstract

AIM: To analyze the relevance of the microRNA miR-196a for colorectal oncogenesis.
METHODS: The impact of miR-196a on the restriction targets HoxA7, HoxB8, HoxC8 and HoxD8 was analyzed by reverse transcription polymerase chain reaction (RT-PCR) after transient transfection of SW480 cancer cells. The miR-196a transcription profile in colorectal cancer samples, mucosa samples and diverse cancer cell lines was quantified by RT-PCR. Transiently miR-196a-transfected colorectal cancer cells were used for diverse functional assays in vitro and for a xenograft lung metastasis model in vivo.
RESULTS: HoxA7, HoxB8, HoxC8 and HoxD8 were restricted by miR-196a in a dose-dependent and gene-specific manner. High levels of miR-196a activated the AKT signaling pathway as indicated by increased phosphorylation of AKT. In addition, high levels of miR-196a promoted cancer cell detachment, migration, invasion and chemosensitivity towards platin derivatives but did not impact on proliferation or apoptosis. Furthermore, miR-196a increased the development of lung metastases in mice after tail vein injection.
CONCLUSION: miR-196a exerts a pro-oncogenic influence in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19418581      PMCID: PMC2678579          DOI: 10.3748/wjg.15.2089

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  microRNAs: tiny regulators with great potential.

Authors:  V Ambros
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

2.  Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.

Authors:  Eric C Lai
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

Review 3.  Role of microRNAs in plant and animal development.

Authors:  James C Carrington; Victor Ambros
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

4.  Cancer statistics, 2000.

Authors:  R T Greenlee; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  2000 Jan-Feb       Impact factor: 508.702

5.  HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.

Authors:  P S Knoepfler; D B Sykes; M Pasillas; M P Kamps
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

6.  Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation.

Authors:  David Waltregny; Younes Alami; Nathalie Clausse; Jean de Leval; Vincent Castronovo
Journal:  Prostate       Date:  2002-02-15       Impact factor: 4.104

7.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

8.  Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

Authors:  Gillian Smith; Francis A Carey; Julie Beattie; Murray J V Wilkie; Tracy J Lightfoot; Jonathan Coxhead; R Colin Garner; Robert J C Steele; C Roland Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

Review 9.  Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Authors:  Hannah K Weir; Michael J Thun; Benjamin F Hankey; Lynn A G Ries; Holly L Howe; Phyllis A Wingo; Ahmedin Jemal; Elizabeth Ward; Robert N Anderson; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2003-09-03       Impact factor: 13.506

10.  Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

Authors:  Gary J Miller; Heidi L Miller; Adrie van Bokhoven; James R Lambert; Priya N Werahera; Osvaldo Schirripa; M Scott Lucia; Steven K Nordeen
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  90 in total

1.  Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by vascular endothelial growth factor (VEGF)-induced inhibition of miR-196a expression.

Authors:  Anne-Laure Pin; François Houle; Patrick Fournier; Maëva Guillonneau; Éric R Paquet; Martin J Simard; Isabelle Royal; Jacques Huot
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 2.  MicroRNAs involved in the browning process of adipocytes.

Authors:  N Arias; L Aguirre; A Fernández-Quintela; M González; A Lasa; J Miranda; M T Macarulla; M P Portillo
Journal:  J Physiol Biochem       Date:  2015-12-22       Impact factor: 4.158

3.  Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.

Authors:  Keun Hur; Yuji Toiyama; Aaron J Schetter; Yoshinaga Okugawa; Curtis C Harris; C Richard Boland; Ajay Goel
Journal:  J Natl Cancer Inst       Date:  2015-02-06       Impact factor: 13.506

4.  MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.

Authors:  Chenggang Wang; Ren Ren; Haolin Hu; Changjun Tan; Miao Han; Xiaolin Wang; Yun Zheng
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

5.  High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.

Authors:  Naohide Oue; Katsuhiro Anami; Aaron J Schetter; Markus Moehler; Hirokazu Okayama; Mohammed A Khan; Elise D Bowman; Annett Mueller; Arno Schad; Manabu Shimomura; Takao Hinoi; Kazuhiko Aoyagi; Hiroki Sasaki; Masazumi Okajima; Hideki Ohdan; Peter R Galle; Wataru Yasui; Curtis C Harris
Journal:  Int J Cancer       Date:  2013-11-08       Impact factor: 7.396

6.  MicroRNA-630 is a prognostic marker for patients with colorectal cancer.

Authors:  Dake Chu; Jianyong Zheng; Jipeng Li; Yunming Li; Jian Zhang; Qingchuan Zhao; Weizhong Wang; Gang Ji
Journal:  Tumour Biol       Date:  2014-07-01

7.  Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a.

Authors:  Vanessa Villegas-Ruiz; Sergio Juárez-Méndez; Oscar A Pérez-González; Hugo Arreola; Lucero Paniagua-García; Miriam Parra-Melquiadez; Raúl Peralta-Rodríguez; Ricardo López-Romero; Alberto Monroy-García; Alejandra Mantilla-Morales; Guillermo Gómez-Gutiérrez; Edgar Román-Bassaure; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 8.  How microRNAs influence both hereditary and inflammatory-mediated colon cancers.

Authors:  Jennifer Hutchison; Zoe Cohen; Benjamin C Onyeagucha; Janet Funk; Mark A Nelson
Journal:  Cancer Genet       Date:  2013-09-14

Review 9.  The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis.

Authors:  Zhen-Yao Chen; Xin Chen; Zhao-Xia Wang
Journal:  Tumour Biol       Date:  2016-10-18

10.  Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population.

Authors:  Sheng Peng; Zhongshen Kuang; Chenyi Sheng; Yan Zhang; Hang Xu; Qinghong Cheng
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.